Whether it’s treating rare tumor types or working to harness the power of antibody drug-conjugates (ADC) and radioligand therapies (RLTs), we’re constantly looking for new ways to deliver innovative #oncology medicines that help people living with #cancer. Learn more about our unique approach to cancer research: https://e.lilly/3S6dnA7 #NationalCancerResearchMonth
Loxo@Lilly
Pharmaceutical Manufacturing
Stamford, CT 44,842 followers
Wholly owned subsidiary of Eli Lilly and Company
About us
Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients. Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain. When you engage with Loxo@Lilly on LinkedIn (and any other of Lilly's social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: https://e.lilly/guidelines
- Website
-
http://www.loxooncology.com
External link for Loxo@Lilly
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Stamford, CT
- Type
- Public Company
- Specialties
- Oncology and Biopharmaceuticals
Locations
-
Primary
Get directions
281 Tresser Blvd
9th Floor
Stamford, CT 06901, US
-
Get directions
701 Gateway Blvd
Suite 420
South San Francisco, CA 94080, US
-
Get directions
3122 Sterling Circle
Boulder, Colorado 80301, US
-
Get directions
281 Tresser Blvd
Stamford, CT 06901, US
Employees at Loxo@Lilly
Updates
-
We’re celebrating #MothersDay with a coffee break and a moment with #OncologyOnCanvas. “Mom’s Journey” spotlights the powerful connection between motherly figures and children, inspired by the author’s experience supporting her mother through #BreastCancer. #WeAreLilly
-
Some U.S. veterans who experienced environmental exposures during active duty have an increased risk of developing #ChronicLymphocyticLeukemia (CLL) and #SmallLymphocyticLymphoma (SLL). We’re continuously working to improve the treatment landscape to support patients, including veterans, who are fighting #BloodCancer. Explore more resources from the CLL Society: https://e.lilly/3vswgVt
-
Following her #EarlyBreastCancer (EBC) diagnosis in March 2020, Christa Wilson decided to chronicle her #cancer journey online in the hope of becoming a beacon of hope for others. Learn more about her story: https://e.lilly/49v9QRT #WeAreLilly
-
-
We're proud sponsors of this weekend's HOPE Summit, a one-of-a-kind conference organized by LUNGevity Foundation. Join us as we support #LungCancer survivors and caregivers on their journey to navigate treatment and build a strong community of support: https://e.lilly/3Jps0JG #HopeSummit24 #ThisIsHope
-
-
It’s time for a coffee break with #OncologyOnCanvas! The “Voices of Women Butterfly Quilt” celebrates the 5th anniversary of a breast cancer survivor, inspired by the meticulous stitches of her reconstructive surgeons that have helped put so many women back together after cancer. Read about their story and explore more art: https://e.lilly/41rlbQ5 #WeAreLilly
-
-
Today, Eli Lilly and Company announced Q1 2024 financial results, including that oncology had a strong start to the year. Read more here: https://e.lilly/44hUO0l
We continue making progress on our goal to help more people get better. Read more about our Q1 results https://e.lilly/44hUO0l.
-
In a new micro-documentary from RETpositive, both patients and healthcare providers emphasize the importance of supportive resources to help people navigate a #cancer diagnosis. Hear about the challenges faced by people with RET-positive #cancer: https://e.lilly/3U6tJd1 #IAmRETpositive
I Am RETpositive: Who We Are
https://www.youtube.com/
-
We’re excited to announce the start of our phase I/II trial investigating a next generation prostate-specific membrane antigen (PSMA)-targeting ligand optimized for delivering #actinium #radioligand therapy in biochemically recurrent and metastatic castration-resistant #ProstateCancer. Learn more about the trial here: https://e.lilly/49lmZgC
-
Congratulations Winselow Tucker, Senior Vice President and Chief Commercial Officer, for being named one of Savoy Magazine’s 2024 Most Influential Executives in Corporate America. Thank you for your commitment to the community both within and outside of Lilly. Read more about Winselow and the other executives named here: https://e.lilly/4aRtTKT #WeAreLilly
-